Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial

Overview of attention for article published in Arthritis Research & Therapy, December 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 8 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Pegloticase and Methotrexate Co-Therapy Improved Urate Burden, Patient-Reported Outcomes in Gout

HCP Live, 13 Jan 2023

Treating patients with gout with concurrent pegloticase and methotrexate (MTX) therapy resulted in lowered serum urate levels…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.